A comment on Boyers et al.: "eltrombopag for the treatment of chronic immune or idiopathic thrombocytopenic purpura: a NICE single technology appraisal".
作者信息
Allen Rachel, Brainsky Andres, Grotzinger Kelly, Roccia Tito
出版信息
Pharmacoeconomics. 2013 Jan;31(1):87-9. doi: 10.1007/s40273-012-0003-8.
Abstract
摘要
相似文献
1
A comment on Boyers et al.: "eltrombopag for the treatment of chronic immune or idiopathic thrombocytopenic purpura: a NICE single technology appraisal".对博耶斯等人的评论：“艾曲泊帕用于治疗慢性免疫性或特发性血小板减少性紫癜：英国国家卫生与临床优化研究所单一技术评估”
Pharmacoeconomics. 2013 Jan;31(1):87-9. doi: 10.1007/s40273-012-0003-8.
2
The authors' reply to Allen et al.: "A Comment on Boyers et al.: 'eltrombopag for the treatment of chronic immune or idiopathic thrombocytopenic purpura: a NICE single technology appraisal'".作者对艾伦等人的回复：“对博耶斯等人的评论：‘艾曲泊帕用于治疗慢性免疫性或特发性血小板减少性紫癜：英国国家卫生与临床优化研究所单一技术评估’”
Pharmacoeconomics. 2013 Jan;31(1):91. doi: 10.1007/s40273-012-0005-6.
3
Eltrombopag for the treatment of chronic immune or idiopathic thrombocytopenic purpura: a NICE single technology appraisal.依曲泊帕治疗慢性免疫性或特发性血小板减少性紫癜：一项 NICE 单技术评估。
Pharmacoeconomics. 2012 Jun 1;30(6):483-95. doi: 10.2165/11591550-000000000-00000.
4
Eltrombopag in chronic idiopathic thrombocytopenic purpura.艾曲泊帕用于慢性特发性血小板减少性紫癜
Lancet. 2009 Feb 21;373(9664):607-8. doi: 10.1016/S0140-6736(09)60377-9.
5
Acute Myocardial Infarction Due to Eltrombopag Therapy in a Patient with Immune Thrombocytopenic Purpura.一名免疫性血小板减少性紫癜患者接受艾曲泊帕治疗后发生急性心肌梗死
Turk J Haematol. 2017 Mar 1;34(1):107-108. doi: 10.4274/tjh.2016.0169. Epub 2016 Dec 12.
6
Successful eltrombopag treatment of refractory idiopathic thrombocytopenic purpura associated with Crohn disease.艾曲泊帕成功治疗与克罗恩病相关的难治性特发性血小板减少性紫癜。
Clin Res Hepatol Gastroenterol. 2015 Apr;39(2):e23-4. doi: 10.1016/j.clinre.2014.10.011. Epub 2014 Nov 13.
7
Eltrombopag for chronic immune thrombocytopenia.艾曲泊帕用于慢性免疫性血小板减少症。
Lancet. 2016 Jan 23;387(10016):336. doi: 10.1016/S0140-6736(16)00107-0.
8
Eltrombopag for chronic immune thrombocytopenia - Authors' reply.艾曲泊帕用于慢性免疫性血小板减少症——作者回复
Lancet. 2016 Jan 23;387(10016):336-337. doi: 10.1016/S0140-6736(16)00009-X.
9
Eltrombopag Effectiveness and Tolerability in Chronic Immune Thrombocytopenia: A Meta-Analysis.依鲁替尼治疗慢性免疫性血小板减少症的疗效和耐受性：一项荟萃分析。
Clin Appl Thromb Hemost. 2021 Jan-Dec;27:10760296211005555. doi: 10.1177/10760296211005555.
10
Update on eltrombopag for ITP.艾曲泊帕治疗免疫性血小板减少症的最新进展。
Oncology (Williston Park). 2009 Nov 30;23(13):1177-8.
引用本文的文献
1
Cost-consequence model comparing eltrombopag and romiplostim in pediatric patients with chronic immune thrombocytopenia.比较艾曲泊帕和罗米司亭治疗儿童慢性免疫性血小板减少症的成本-后果模型
Clinicoecon Outcomes Res. 2018 Nov 5;10:715-721. doi: 10.2147/CEOR.S177338. eCollection 2018.
2
Cost-consequence model comparing eltrombopag versus romiplostim for adult patients with chronic immune thrombocytopenia.比较艾曲泊帕与罗米司亭治疗成人慢性免疫性血小板减少症的成本-后果模型
Clinicoecon Outcomes Res. 2018 Nov 1;10:705-713. doi: 10.2147/CEOR.S177324. eCollection 2018.
3
The authors' reply to Allen et al.: "A Comment on Boyers et al.: 'eltrombopag for the treatment of chronic immune or idiopathic thrombocytopenic purpura: a NICE single technology appraisal'".作者对艾伦等人的回复：“对博耶斯等人的评论：‘艾曲泊帕用于治疗慢性免疫性或特发性血小板减少性紫癜：英国国家卫生与临床优化研究所单一技术评估’”
Pharmacoeconomics. 2013 Jan;31(1):91. doi: 10.1007/s40273-012-0005-6.
本文引用的文献
1
Eltrombopag for the treatment of chronic immune or idiopathic thrombocytopenic purpura: a NICE single technology appraisal.依曲泊帕治疗慢性免疫性或特发性血小板减少性紫癜：一项 NICE 单技术评估。
Pharmacoeconomics. 2012 Jun 1;30(6):483-95. doi: 10.2165/11591550-000000000-00000.
2
Eltrombopag for management of chronic immune thrombocytopenia (RAISE): a 6-month, randomised, phase 3 study.艾曲波帕治疗慢性免疫性血小板减少症（RAISE）：6 个月随机、3 期研究。
Lancet. 2011 Jan 29;377(9763):393-402. doi: 10.1016/S0140-6736(10)60959-2. Epub 2010 Aug 23.
3
Efficacy of romiplostim in patients with chronic immune thrombocytopenic purpura: a double-blind randomised controlled trial.罗米司亭治疗慢性免疫性血小板减少性紫癜患者的疗效：一项双盲随机对照试验。
Lancet. 2008 Feb 2;371(9610):395-403. doi: 10.1016/S0140-6736(08)60203-2.
4
The results of direct and indirect treatment comparisons in meta-analysis of randomized controlled trials.随机对照试验荟萃分析中直接和间接治疗比较的结果。
J Clin Epidemiol. 1997 Jun;50(6):683-91. doi: 10.1016/s0895-4356(97)00049-8.
Zotero 插件